Cerebral injury and retinopathy as risk factors for blindness in extremely preterm infants
- PMID: 39332892
- PMCID: PMC11946922
- DOI: 10.1136/archdischild-2024-327707
Cerebral injury and retinopathy as risk factors for blindness in extremely preterm infants
Abstract
Objective: This study investigates whether and to what extent cerebral injury is associated with bilateral blindness in extremely preterm infants, which has been attributed mainly to retinopathy of prematurity (ROP).
Design: Multicentre analysis of children born from 1994 to 2021 at gestational age 22 0/7 to 28 6/7 weeks with follow-up at 18-26 months. Logistic regression examined the adjusted association of bilateral blindness with severe ROP and/or cerebral injury among extremely preterm infants.
Exposures: Severe ROP and cerebral injury, the latter defined as any of the following on cranial imaging: ventriculomegaly; blood/increased echogenicity in the parenchyma; cystic periventricular leukomalacia.
Main outcome measures: Bilateral blindness, defined as a follow-up examination meeting criteria of 'blind-some functional vision' or 'blind-no useful vision' in both eyes.
Results: The 19 863 children included had a mean gestational age of 25.6±1.7 weeks, mean birth weight of 782±158 g and 213 (1%) had bilateral blindness. Multiplicative interaction between ROP and cerebral injury was statistically significant. For infants with only severe ROP (n=3130), odds of blindness were 8.14 times higher (95% CI 4.52 to 14.65), and for those with only cerebral injury (n=2836), odds were 8.38 times higher (95% CI 5.28 to 13.28), compared with the reference group without either condition. Risks were not synergistic for infants with both severe ROP and cerebral injury (n=1438, adjusted OR=28.7, 95% CI 16.0 to 51.7, p<0.0001).
Conclusions: In a group of extremely preterm infants, severe ROP and cerebral injury were equally important risk factors for blindness. Besides ROP, clinicians should consider cerebral injury as a cause of blindness in children born extremely preterm.
Trial registration number: NCT00063063.
Keywords: Infant Development; Intensive Care Units, Paediatric; Neonatology; Neurology; Ophthalmology.
© Author(s) (or their employer(s)) 2025. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ Group.
Conflict of interest statement
Competing interests: NA is an advisor to ResBiotic and Alveolus Bio and serves on the Data and Safety Monitoring Board for Shire/Oak Hill Bio. CMC has a consulting agreement with ReAlta Life Sciences (for a new drug in clinical trials for hypoxic ischaemic encephalopathy), and IP in a company, CryoCell (for a cell therapy for HIE). AD has a grant from the Neonatal Research Network (NRN). CPT is supported by grants from the National Institutes of Health (K23HL157618). CPT is supported by a grant from Owlet Baby Care for an investigator-initiated study (ClinicalTrials.gov identifier: NCT05774470) and also has a patent application pending for a bradycardia predictor and interrupter. VVS is supported by a grant from the American Heart Association (23CDA1048106).
References
Publication types
MeSH terms
Associated data
Grants and funding
- UG1 HD068263/HD/NICHD NIH HHS/United States
- U10 HD021373/HD/NICHD NIH HHS/United States
- UG1 HD087226/HD/NICHD NIH HHS/United States
- UG1 HD068270/HD/NICHD NIH HHS/United States
- UG1 HD053089/HD/NICHD NIH HHS/United States
- KL2 TR003097/TR/NCATS NIH HHS/United States
- U10 HD021397/HD/NICHD NIH HHS/United States
- UG1 HD027856/HD/NICHD NIH HHS/United States
- UG1 HD027904/HD/NICHD NIH HHS/United States
- UG1 HD027880/HD/NICHD NIH HHS/United States
- UL1 TR001117/TR/NCATS NIH HHS/United States
- UG1 HD053109/HD/NICHD NIH HHS/United States
- UG1 HD027851/HD/NICHD NIH HHS/United States
- U10 HD036790/HD/NICHD NIH HHS/United States
- U10 HD053119/HD/NICHD NIH HHS/United States
- U01 HD036790/HD/NICHD NIH HHS/United States
- UG1 HD068244/HD/NICHD NIH HHS/United States
- UG1 HD027853/HD/NICHD NIH HHS/United States
- UG1 HD112093/HD/NICHD NIH HHS/United States
- UG1 HD087229/HD/NICHD NIH HHS/United States
- UG1 HD040689/HD/NICHD NIH HHS/United States
- U10 HD040461/HD/NICHD NIH HHS/United States
- M01 RR016587/RR/NCRR NIH HHS/United States
- U10 HD034167/HD/NICHD NIH HHS/United States
- UG1 HD034216/HD/NICHD NIH HHS/United States
- U10 HD027871/HD/NICHD NIH HHS/United States
- K23 HL157618/HL/NHLBI NIH HHS/United States
- M01 RR007122/RR/NCRR NIH HHS/United States
- UG1 HD068284/HD/NICHD NIH HHS/United States
- UG1 HD021385/HD/NICHD NIH HHS/United States
- UG1 HD040492/HD/NICHD NIH HHS/United States
- UG1 HD021364/HD/NICHD NIH HHS/United States
- U10 HD040498/HD/NICHD NIH HHS/United States
- UG1 HD068278/HD/NICHD NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical